ERBB2 and neoplasm: The difference in HRs was greatest amongst HER2-enriched tumours (HR was 1.71 for imputed cohort compared to 4.68 in the complete case cohort) and TNBC (HR was 2.74 in the imputed cohort compared to 4.70 in the complete case cohort) subtypes.